Maryland scholars on Monday alternately described President-elect Donald Trump’s pick to lead the U.S. Food and Drug Administration — Dr. Marty Makary, a Johns Hopkins researcher, surgeon and author — as a “courageous leader” and a “reasonable choice,” who nevertheless espouses some “worrisome” views.

President-elect Trump has picked Marty Makary, a Johns Hopkins’s surgeon who has espoused contrarian views about the COVID-19 pandemic, to lead the Federal Drug Administration. Makary is a surgical oncologist at Johns Hopkins University and an author.

STAT reporters reached out to key figures in biotech, pharma, and medical devices to find out what they think about President-elect Trump’s pick of Johns Hopkins pancreatic surgeon Martin “Marty” Makary as commissioner of the Food and Drug Administration.